Squarepoint’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-20,584
| Closed | -$117K | – | 4814 |
|
|
2025
Q3 | $117K | Buy |
+20,584
| New | +$105K | ﹤0.01% | 4082 |
|
|
2024
Q3 | – | Sell |
-19,554
| Closed | -$85.1K | – | 4634 |
|
|
2024
Q2 | $85.1K | Sell |
19,554
-42,709
| -69% | -$188K | ﹤0.01% | 3824 |
|
|
2024
Q1 | $313K | Buy |
62,263
+12,209
| +24% | +$68.4K | ﹤0.01% | 3349 |
|
|
2023
Q4 | $314K | Buy |
+50,054
| New | +$287K | ﹤0.01% | 3326 |
|
|
2023
Q2 | – | Sell |
-74,205
| Closed | -$673K | – | 3949 |
|
|
2023
Q1 | $673K | Buy |
+74,205
| New | +$544K | ﹤0.01% | 2134 |
|
|
2020
Q4 | – | Sell |
-10,264
| Closed | -$76K | – | 3219 |
|
|
2020
Q3 | $76K | Sell |
10,264
-25,711
| -71% | -$201K | ﹤0.01% | 2326 |
|
|
2020
Q2 | $265K | Buy |
35,975
+14,173
| +65% | +$124K | ﹤0.01% | 1683 |
|
|
2020
Q1 | $161K | Sell |
21,802
-32,913
| -60% | -$239K | ﹤0.01% | 1543 |
|
|
2019
Q4 | $310K | Buy |
+54,715
| New | +$280K | ﹤0.01% | 2022 |
|
Squarepoint's SCPH Position: Q4 2025 in Review
Squarepoint sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 20,584 shares — an estimated $117K sold.
Squarepoint first reported a position in SCPH in Q4 2019 and held it in 9 quarters. The position peaked at $673K in Q1 2023. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.
- Squarepoint reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
- Squarepoint sold 20,584 scPharmaceuticals shares in Q4 2025, an estimated $117K.
- Squarepoint first reported a position in scPharmaceuticals in Q4 2019 and held it in 9 quarters.
- Squarepoint's scPharmaceuticals position peaked at $673K in Q1 2023.
- 0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.
Based on Squarepoint's 13F filing for Q4 2025, filed 13 Feb 2026.